Materials, Design & Engineering for Sensor Manufacturing

 

センサー製造のための材料、設計、技術
センサーの設計と統合の最適化

ウェアラブルデバイスや埋め込み型デバイス、デジタルヘルス、環境、物流、セキュリティ、ホームオートメーション、産業などさまざまな応用分野に対応する次世代のスマートセンサーが登場したことにより、過去10年間で市場は大きく成長しました。このカンファレンスプログラムは、各種の応用分野におけるセンサーの需要拡大に対応するうえで極めて重要な意味を持つ材料や設計、技術の最適化と効率的な製造の実現にスポットライトを当てるもので、新たなセンサー市場についての分析や製造技術に関する研究開発の最新の成果などが紹介されます。

12月10日(火)

7:30 am Registration and Morning Coffee

全体セッション

8:20 Chairperson's Remarks

Christopher Hartshorn, PhD, Program Director, Cancer Treatment & Diagnosis, National Institutes of Health; National Cancer Institute

8:30 Wear, implant and analyze: sensors and the future of chronic care

Rafael Carbunaru, PhD, Vice President R&D, Boston Scientific

As rates of chronic disease climb, so do opportunities for wearable and implantable solutions to help manage them. Core technology and sensor improvements; integration into healthcare systems; robust security; and personalized experience could all speed adoption. This talk will address current market and opportunities, and include examples of using wearables, sensors and analytics in a proof-of-concept clinical study and life-saving AI for chronic disease applications.

9:00 Regulatory Considerations during Mobile Medical App Development for Commercial and Clinical Trial Use

Mike Benecky, Senior Director, Global Regulatory Affairs in Precision and Digital Medicine, GlaxoSmithKline

Mobile medical apps are defined as medical devices from their intended use. Mobile medical app regulation is health risk-based to balance patient safety and barriers to technological innovation. Medical device patient risk analysis is a critical prerequisite prior to sensor/app inclusion within a clinical trial. Key components of quality management systems for mobile medical apps include: software requirements/specifications, user acceptance testing, software postmarket surveillance, software version control, and medical device adverse event reporting.             

9:30 Nanotechnology, MEMS, Microfluidics for Health 4.0 Hypermobility

Anita Rogacs, PhD, Head of Life Sciences Strategy and R&D, HP Labs

New imperatives of healthcare are focusing on prevention, personalization of diagnostics and treatment, and democratization, including access to everyone, anywhere, anytime at a low cost. The technology convergence in medicine is enabled by the powerful combination of microelectronics, microfluidics, advanced (bio)-chemistry, distributed network, and data analytics.

10:00 Networking Coffee Break

10:30 Roundtable Discussions

Roundtable discussions are informal, moderated discussions with brainstorming and interactive problem solving, allowing participants from diverse backgrounds to exchange ideas and experiences and develop future collaborations around a focused topic. Each topic is led by a moderator who ensures focused conversation around the key issues of that topic. Attendees choose to join a specific group.

TABLE 1: How Biosensors Can Address Global Health Challenges

Lisa Diamond, CEO, Pinpoint Science LLC

  • Where can access to biosensor solutions save lives in the developing world?
  • How can novel biosensor technologies contribute to fighting emerging pandemic threats?
  • What new tools can be offered to consumers to monitor and diagnose their own health status?
  • How do we best handle data collected from connected biosensors, protecting patient privacy while informing public health agencies?
  • What new applications for biosensors are needed in veterinary medicine, agriculture and food safety? 

Table 2: Power Solutions for Miniaturized Implants

Robert Rubino, Senior Director, Research and Development, Integer

  • How can we improve power technology to make powered implants smaller and more convenient?
  • What wireless power solutions are available?
  • What new battery and capacitor solutions are available that enable smaller devices?
  • What are the technical hurdles that these new technologies need to overcome and how do we get there?

Table 3: Mixed-Signal Application Specific Integrated Circuits (ASICs): Advantages, Challenges, Justification, and Strategies

Andrew Kelly, BSEE, Director of Applications Engineering, Semiconductor Division, Cirtec Medical

  • What advantages are offered by Application Specific Integrated Circuits (ASICs)?
  • What are the primary challenges associated with an ASIC-based design?
  • What are the most common applications that justify the challenges of an ASIC-based design?
  • How do you approach the system/circuit partition when developing an ASIC-based design?
  • What factors should be considered when deciding to either work with an ASIC supplier or develop an ASIC in-house?
  • What are the most important factors when selecting an ASIC supplier?

Table 4: Overcoming the Challenges to Bringing Medical Devices to The Market

David DiPaola, Managing Director, DiPaola Consulting

  • What were your biggest challenges bringing a medical device to market and what solutions did you implement?  
  • How were you able to expedite the FDA approval process and when in the development did you get the FDA involved?  
  • How do you recommend shorting the time to market for a medical device?  
  • What issues did you face in pilot production that were not identified in in the development stage and what steps did you take to address this?
  • How did you incorporate manufacturing, test and dimensional measurement requirements into your design up front?  What tools did you use?  

Table 5: Advanced Materials

Stacey Standridge, PhD, Deputy Director, National Nanotechnology Coordination Office

  • What advanced materials are you working with?
  • What specific performance, cost, or other benefits are you targeting with these materials?
  • What are the bottlenecks in deploying advanced materials in devices (e.g., technical performance, manufacturing scale, reproducibility, integration, standards, financial considerations)
  • What are potential mechanisms to address these bottlenecks?
  • What lessons can be learned from prior technologies in evolution of scale, reproducibility, and quality control? Are there any new challenges that are unique to your advanced material?

Table 6: Sensors for Collaborative or Autonomous Systems: Challenges and Considerations

Tom Calef, CTO, Activ Surgical

  • What industries are exploring such systems and what can be learned from them?
  • What sensor types and circuit architectures are well-suited for such systems?
  • What factors should be considered when deciding to either work with a sensor supplier or develop in-house?
  • What are current user-acceptance or regulatory/compliance challenges and successful case studies for overcoming them?
  • How is data being collected, stored, and used in today’s learning models?  What are the best practices for specific industries?
  • What is required for these systems to take the next “big leap” into Level 3 autonomous behavior or beyond?

市場と商業化への道

11:25 Chairperson's Remarks

Steve Lerner, CEO, Alpha Szenszor

11:30 BARDA’s New Division of Research Innovation for the Development of Next-Generation Wearables

Justin Yang, Program Analyst, Biomedical Advanced R&D Authority, US Dept of Health & Human Svcs

This presentation will provide an overview of the vision of the Biomedical Advanced Research & Development Authority's new Division of Research, Innovation, and Ventures in the Department of Health and Human Services and their new focus on wearable technologies. We are funding multiple projects seeking to improve healthcare and health outcomes by enabling Americans to monitor their own health. We seek wearable technologies to enable a notification of impending disease before symptoms arise.

先進的なセンサーの材料と技術

12:00 pm Miniaturization Technologies for Implantable Devices

Robert Rubino, Senior Director, Research and Development, Integer

In order to make future implantable medical devices as minimally invasive and cost-effective as possible, devices will need to become smaller and easier to implant. This will require the development of alternative assembly technologies and materials. Reduction in the size of the power source, while still retaining the high level of reliability required, will be one critical element to reduce device size. New concepts to allow for miniature scale assembly of hermetic, biocompatible coin cells and thin film cells have been developed by leveraging traditional glass-to-metal and ceramic-to-metal seal technologies. Ceramic  device enclosures, which allow for more efficient energy transfer to the device from external power sources due to reduced eddy currents, have been developed to minimize recharge time or eliminate the need for a power source completely. In addition, biocompatible, hermetic conductive vias through ceramic substrates enable further size reduction of device feedthroughs and can act as active electrodes for sensing or therapy. Combined, these technologies can be used to produce sensing and stimulating implants that provide enhanced convenience for patients and physicians.

12:30 Sponsored Presentation (Opportunity Available)

1:00 Enjoy Lunch on Your Own

先進的なセンサーの材料と技術

1:55 Chairperson's Remarks

Roger Grace, President, Roger Grace Associates

2:00 Radio Ranging with Ultra-High Resolution with Passive Markers

Edwin Kan, Prof, Electrical & Computer Engineering, Cornell Univ

Accurate locating of specific points indoors is critical for robotic feedback control and non-intrusive structural integrity monitoring. Here we show that a 1 GHz harmonic RFID system can provide a ranging resolution of less than 50 microns in air and less than 5 microns in water with a sampling rate of greater than 1 kHz in continuous 7cm travel at a distance of 2.5m.

2:30 Low Power, Highly Scaled IoT Gas Sensors Using Carbon Nanotubes

Steve Lerner, CEO, Alpha Szenszor Inc

In the world of gas sensors that currently contend for Edge-based detection, incumbent technologies carry significant limitations with respect to integration, cost and power consumption. Sensor power consumption is a fundamental constraint for all portable sensing devices, particularly as the vision of energy harvesting and ubiquitous sensing at the Edge materialize. More recently, Carbon Nanotube sensors have evolved to being one of the most cost-effective options with greater packing density, higher sensitivity and selectivity, than most gas sensors, while consuming up to 3 orders of magnitude less power. This talk will discuss the inherent advantages of ultra-low power gas sensors and some of the applications that are being enabled as a result. From medical diagnostics to fitness monitors to environmental applications analyzing the quality of air, soil, water and food. CNT sensors are positioned to revolutionize our automated sense of smell and taste.

3:00 The Integration of Flexible Tactile Sensors into Biomedical and Consumer Products

Rob M Podoloff, MSME, CTO, Tekscan, Inc.

This talk will focus on the information that flexible tactile sensors can provide and the process for integrating them into consumer products. Several applications examples ranging from prevention of occlusion in insulin delivery lines to the measurement of dynamic automobile tire footprints will be presented along with a live demonstration of the technology.

3:30 Refreshment Break in the Exhibit Hall with Poster Viewing

4:00 Tutorials (See page 3 for details.)

6:00 Welcome Reception in the Exhibit Hall with Poster Viewing

7:00 End of Day

12月11日(水)

8:00 am Registration and Morning Coffee

全体セッション

8:20 Chairperson's Remarks

Robert Rubino, Senior Director, Research and Development, Integer

8:30 Dexcom's Continuous Glucose Monitoring (CGM) Technology and Its Impact on Diabetes Management, Artificial Pancreas, & Digital Health Systems

Peter Simpson, Vice President of Sensor R&D and Advanced Technology, Dexcom

Recent advances in continuous glucose monitoring (CGM) technology have significantly increased its usability and impact on diabetes management.  CGM's are now widely reimbursed and are rapidly becoming the standard of care for people on intensive insulin therapy.This presentation will provide an overview of Dexcom's CGM sensor technology, its use in digital health and artificial pancreas systems and a preview of our future products.

9:00 Objective Measures for Clinical Assessment and Precise Understanding of Disease Progression

Christopher Hartshorn, PhD, Program Director, Cancer Treatment & Diagnosis, National Institutes of Health; National Cancer Institute

This talk will look at various efforts across the National Institutes of Health attempting to enable more objective measures for out-of-clinic, patient-specific assessment and longitudinal understanding of disease progression in large cohorts.

9:30 Wearable Electrochemical Sensors - Recent Advances

Joseph Wang, Distinguished Professor & Chair, Nanoengineering, University of California, San Diego

This presentation will discuss recent developments in the field of wearable electrochemical sensors integrated directly on the epidermis or within the mouth for various non-invasive biomedical monitoring applications. Particular attention will be given to non-invasive monitoring of metabolites and electrolytes using flexible amperometric and potentiometric sensors, respectively, along with related materials, energy and integration considerations. The preparation and characterization of such wearable electrochemical sensors will be described, along with their current status, future prospects, and challenges. 

10:00 Coffee Break in the Exhibit Hall with Poster Viewing

10:30 Roundtable Discussions

Roundtable discussions are informal, moderated discussions with brainstorming and interactive problem solving, allowing participants from diverse backgrounds to exchange ideas and experiences and develop future collaborations around a focused topic. Each topic is led by a moderator who ensures focused conversation around the key issues of that topic. Attendees choose to join a specific group.

Table 1: Miniaturization for Chemical and Biological Detection

Cory Bernhards, PhD, Research Microbiologist, CBR, Defense Threat Reduction Agency

  • How do you decide what to prioritize?
  • Continuous improvement in sensitivity and specificity

Table 2: Best Practices for AI, IoT, etc

Aminat Adebiyi, PhD, Research Staff Member,Biomedical IoT and Applied Analytics, IBM

  • We hear about what’s worked at conferences, but what about what hasn’t worked?
  • What standards do we like? What don’t we like?

Table 3: The Small Business Innovation Research (SBIR) program and Small Business Technology Transfer (STTR)

Dr. Juan Figueroa, Puerto Rico Science and Technology Trust

  • When was the first time you heard about SBIR/STTR? What are the similarities and differences from what you heard today?
  • Are you aware of any SBIR/STTR award winner? Are you aware of a company with a potential for >$1M equity free and hold on to IP? Why wouldn’t you invest in it/them? Why would you invest in it/them? 
  • Are you afraid the federal government will take the IP? 
  • Are you afraid the grantees (contractors) do not have the experience to move the company forward? 
  • Do you have a horror story about an SBIR/STTR company? A positive story? What went wrong? What went right?
  • What do you want to hear to make you look favorably towards investing in an SBIR/STTR grantee?  

Table 4: Non-Invasive Physiological Monitoring Beyond Activity, PPG, RR and ECG - Adding More Medically Relevant Vital Signs

Ashish V. Pattekar, Principal Scientist, PARC, a Xerox Company

  • What will next generation physiological monitoring sensors and systems look like?
  • What technologies will need to be developed to enable continuous (e.g., wearable) monitoring of additional, medically relevant, vital signs?
  • Can raw data from existing sensors be used to infer other vital parameters using AI / ML approaches?
  • Would there be a net gain from the consumerization of these new sensing modalities (cost versus benefit of resulting follow up / treatment)?
  • What are the risks to the end-user, and can we think of approaches to mitigate them?

Table 5: Considerations for use of Sensor-measured Digital Endpoints during Drug Clinical Development

Mike Benecky, Senior Director, Global Regulatory Affairs in Precision and Digital Medicine, GlaxoSmithKline

  • What further work needs to done to establish an  “off-the-shelf” 510k cleared sensor device as a Digital Clinical Outcome Measure in a Pivotal Drug Study?
  • What added value do digital sensors bring to the drug clinical development process?
  • What are the regulatory challenges during utilization of a novel digital endpoint during a registrational drug clinical trial?
  • What therapeutic areas appear most fertile for use of digital endpoints during drug clinical development

共同開発構想を通じたセンサー商業化の実現

11:25 Chairperson's Remarks

Robert Rubino, Senior Director, Research and Development, Integer

11:30 The NNI Sensors Signature Initiative: Facilitating Collaboration to Advance Nanosensor Development and Commercialization

Stacey Standridge, PhD, Deputy Director, National Nanotechnology Coordination Office

The NNI’s Nanotechnology for Sensors and Sensors for Nanotechnology Signature Initiative (Sensors NSI) coordinates efforts and stimulates existing and emerging projects across federal agencies to explore the use of nanotechnology for the development and commercialization of sensors. This presentation will provide an update regarding current and planned activities of the Sensors NSI, with specific focus on needs, funding opportunities, and recent activities related to wearable and implantable sensors. The NNI is a U.S. Government research and development initiative involving 20 departments and independent agencies working together toward the shared vision of “a future in which the ability to understand and control matter at the nanoscale leads to a revolution in technology and industry that benefits society.”

12:00 pm ANSI, the Value of Its Public-Private Partnership

Michelle Deane, Director, Standards Facilitation, Standards Facilitation, American Natl Standards Institute

ANSI enhances both the global competitiveness of U.S. business and the U.S. quality of life by promoting and facilitating voluntary consensus standards and conformity assessment systems, and safeguarding their integrity. One of the great strengths of the U.S. approach to standards and conformance is its “public-private partnership.” This presentation will provide an overview of this partnership, the U.S. standards process and how the Institute bridges the gap between industry and government and enables information exchange and access among standards developing organizations and public-sector leaders, agencies, and legislators.

12:30 Sponsored Presentation (Opportunity Available)

1:00 Enjoy Lunch on Your Own

製造を視野に入れたセンサーの設計と開発

1:55 Chairperson's Remarks

Stacey Standridge, PhD, Deputy Director, National Nanotechnology Coordination Office

2:00 Sputtered Metal Oxide N-P Heterojunctions for Sub-PPM Volatile Organic Compound Sensing

Andrea Fasoli, PhD, Senior Sensor Engineer, RSM, IBM Almaden Research Center

We present the fabrication and characterization of sputtered SnO2/NiO n-p heterojunctions thin films and their response to Volatile Organic Compounds (VOCs) at sub-ppm concentrations. In optimal processing conditions, the response of the films to VOCs can be greatly increased and its dependence on temperature, typically described in the context of a Diffusion-Reaction model, altered. In addition, we show that p-type NiO layers of given thickness can trigger a reversal in the response pattern of ultra-thin n-type SnO2 underlayers.

2:30 The role of software in MEMS sensors: the silent stars of today’s and future applications

Francois Beauchaud, Principal Engineer, Business Development, Bosch Sensortec

MEMS sensors have become the heart of many consumer electronic devices but each application has different requirements resulting in varying needs for fused sensor data.In this talk, we will introduce solutions at different complexity levels of sensor related software such as fusion, user features and deployment of modern edge AI techniques, to provide a stage to the silent stars within our daily devices.

3:00 Enabling Permanently-Powered Deeply Embedded Sensor Systems

Mark Buccini, Dir Advanced Product Platforms, Advanced Product Platforms, Texas Instruments Inc

This presentation describes the architecture choices and design techniques that have been proven to enable deeply embedded sensor systems to operate for a lifetime from a single non-replaceable or rechargeable primary battery source.  The solution discussed is usable as a template to implement permanently-powered fitness, monitoring, portable health care and wearable devices.  A practical step-by-step series of examples build a complete ultra-low power cost-sensitive microcontroller-based embedded system.  Exactly where at a system level power is consumed and how to minimize is it the focus of the presentation. 

3:30 Refreshment Break in the Exhibit Hall with Poster Viewing

4:00 Tutorials (See page 3 for details.)

6:00 End of Day

* 不測の事態により、事前の予告なしにプログラムが変更される場合があります。

Choose your language
Traditional Chinese
Simplified Chinese
Korean
English


更新履歴
2019/11/19
アジェンダ更新
2019/11/08
スポンサー更新
2019/10/31
スポンサー更新
2019/10/11
スポンサー更新
2019/09/10
スポンサー更新
2019/08/27
アジェンダ・スポンサー更新
2019/07/29
アジェンダ・スポンサー更新







メール配信サービス